Erratum: The Role of Vitamin D Receptor in Innate and Adaptive Immunity: A Study in Hereditary Vitamin D-Resistant Rickets Patients (Journal of Clinical Endocrinology and Metabolism (2013) 98, (1685-1693) DOI: 10.1210/jc.2012-3858);The role of Vitamin D receptor in innate and adaptive immunity: A study in hereditary Vitamin D-resistant rickets patients

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 4, 2013, Pages 1685-1693

  Tiosano, Dov ^a,b   Wildbaum, Gizi ^b   Gepstein, Vardit ^a   Verbitsky, Oleg ^b   Weisman, Yosef ^c   Karin, Nathan ^b   Eztioni, Amos ^b  

^a MEYER CHILDREN S HOSPITAL   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE 1; BETA DEFENSIN 4; BINDING PROTEIN; CATHELICIDIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; CCAAT ENHANCER BINDING PROTEIN BETA; CCAAT ENHANCER BINDING PROTEIN EPSILON; COLECALCIFEROL; CYCLIC AMP; CYTOCHROME P450; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 4; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR; VITAMIN D RESPONSE ELEMENT BINDING PROTEIN;

ADAPTIVE IMMUNITY; ADULT; ARG1 GENE; ARTICLE; CAMP GENE; CEBP BETA GENE; CEBP EPSILON GENE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYP27B1 GENE; DEFB4 GENE; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; FEMALE; GENE EXPRESSION REGULATION; GENE TARGETING; HNRNP GENE; HUMAN; HUMAN CELL; IMMUNE DYSREGULATION; INNATE IMMUNITY; LYMPHOCYTE CULTURE; MALE; MONOCYTE; NOS2 GENE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RICKETS; T LYMPHOCYTE; TREATMENT RESPONSE; VDR GENE; VITAMIN SUPPLEMENTATION;

EID: 84876279910     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-2190     Document Type: Erratum

References (44)

1. Hewison M. Vitamin D and immune function: an overview. Proc Nutr Soc. 2012;71:50-61.
2. Brennan A, Katz DR, Nunn JD, et al. Dendritic cells from human tissues express receptors for the immunoregulatory vitamin D3 metabolite, dihydroxycholecalciferol. Immunology. 1987;61:457-461.
3. Hewison M, Freeman L, Hughes SV, et al. Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J Immunol. 2003;170:5382-5390.
4. Adams JS, Liu PT, Chun R, Modlin RL, Hewison M. Vitamin D in defense of the human immune response. Ann NY Acad Sci. 2007; 1117:94-105.
5. Rook GA, Steele J, Ainsworth M, Champion BR. Activation of macrophages to inhibit proliferation of Mycobacterium tuberculosis: comparison of the effects of recombinant gamma-interferon on human monocytes and murine peritoneal macrophages. Immunology. 1986;59:333-338.
6. Etzioni A, Hochberg Z, Pollak S, et al. Defective leukocyte fungicidal activity in end-organ resistance to 1,25-dihydroxyvitamin D. Pediatr Res. 1989;25:276-279.
7. Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006; 311:1770-1773.
8. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol. 2001;1:135-145.
9. Wang TT, Nestel FP, Bourdeau V, et al. Cutting edge: 1,25- dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol. 2004;173:2909-2912.
10. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature. 2002;415:389-395.
11. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol. 2003;3:710-720.
12. Nizet V, Ohtake T, Lauth X, et al. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature. 2001; 414:454-457.
13. Zhang L, Yu W, He T, et al. Contribution of human alpha-defensin 1,2, and 3 to the anti-HIV-1 activity of CD 8 an tiviral factor. Science. 2002;298:995-1000.
14. Liu PT, Schenk M, Walker VP, et al. Convergence of IL-1beta and VDR activation pathwaysinhuman TLR2/1-induced antimicrobial responses. PLoS One. 2009;4:e5810.
15. Daniel C, Sartory NA, Zahn N, Radeke HH, Stein JM. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J Pharmacol Exp Ther. 2008; 324:23-33.
16. Edfeldt K, Liu PT, Chun R, et al. T-cell cytokines differentially control human monocyte antimicrobial responses by regulating vitamin D metabolism. Proc Natl Acad Sci U S A. 2010;107:22593-22598.
17. Lee JS, Yang CS, Shin DM, Yuk JM, Son JW, Jo EK. Nitric oxide synthesis is modulated by 1,25-dihydroxyvitamin D3 and interferon-gamma in human macrophages after mycobacterial infection. Immune Netw. 2009;9:192-202.
18. Gombart AF, Borregaard N, Koeffler HP. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J. 2005;19:1067-1077.
19. Malloy PJ, Hochberg Z, Tiosano D, Pike JW, Hughes MR, Feldman D. The molecular basis of hereditary 1,25-dihydroxyvitamin D3 resistant rickets in seven related families. J Clin Invest. 1990;86: 2071-2079.
20. Tiosano D, Weisman Y, Hochberg Z. The role of the vitamin D receptor in regulating vitamin D metabolism: a study of vitamin D-dependent rickets, type II. J Clin Endocrinol Metab. 2001;86: 1908-1912.
21. Weisman Y, Bab I, Gazit D, Spirer Z, Jaffe M, Hochberg Z. Longterm intracaval calcium infusion therapy in end-organ resistance to 1,25-dihydroxyvitamin D. Am J Med. 1987;83:984-990.
22. Feldman D, Chen T, Cone C, et al. Vitamin D resistant rickets with alopecia: cultured skin fibroblasts exhibit defective cytoplasmic receptors and unresponsiveness to 1,25(OH)2D3. J Clin Endocrinol Metab. 1982;55:1020-1022.
23. Tiosano D, Hadad S, Chen Z, et al. Calcium absorption, kinetics, bone density, and bone structure in patients with hereditary vitamin D-resistant rickets. J Clin Endocrinol Metab. 2011;96:3701-3709.
24. Evans KN, Nguyen L, Chan J, et al. Effects of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on cytokine production by human decidual cells. Biol Reprod. 2006;75:816-822.
25. Fujii S, Shimizu K, Kronenberg M, Steinman RM. Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs. Nat Immunol. 2002;3:867-874.
26. Kubota T, Kawano S, Chih DY, et al. Representational difference analysis using myeloid cells from C/EBP epsilon deletional mice. Blood. 2000;96:3953-3957.
27. Stoffels K, Overbergh L, Giulietti A, Verlinden L, Bouillon R, Mathieu C. Immune regulation of 25-hydroxyvitamin-D3-1alpha-hydroxylaseinhuman monocytes. J Bone Miner Res. 2006;21:37-47.
28. Pabst T, Mueller BU, Zhang P, et al. Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia. Nat Genet. 2001;27:263-270.
29. Park K, Elias PM, Oda Y, et al. Regulation of cathelicidin antimicrobial peptide expression by an endoplasmic reticulum (ER) stress signaling, vitamin D receptor-independent pathway. J Biol Chem. 2011;286:34121-34130.
30. Shin DM, Yuk JM, Lee HM, et al. Mycobacterial lipoprotein activates autophagy via TLR2/1/CD14 and a functional vitamin D receptor signalling. Cell Microbiol. 2010;12:1648-1665.
31. Zella LA, Meyer MB, Nerenz RD, Lee SM, Martowicz ML, Pike JW. Multifunctional enhancers regulate mouse and human vitamin D receptor gene transcription. Mol Endocrinol. 2010;24:128-147.
32. Chen H, Hu B, Allegretto EA, Adams JS. The vitamin D response element-binding protein. A novel dominant-negative regulator of vitamin D-directed transactivation. J Biol Chem. 2000;275:35557-35564.
33. Liu PT, Modlin RL. Human macrophage host defense against Mycobacterium tuberculosis. Curr Opin Immunol. 2008;20:371-376.
34. Hewison M. Vitamin D and the intracrinology of innate immunity. Mol Cell Endocrinol. 2010;321:103-111.
35. Lagishetty V, Liu NQ, Hewison M. Vitamin D metabolism and innate immunity. Mol Cell Endocrinol. 2011;347:97-105.
36. Dhawan P, Wieder R, Christakos S. CCAAT enhancer-binding protein alpha is a molecular target of 1,25-dihydroxyvitamin D3 in MCF-7 breast cancer cells. J Biol Chem. 2009;284:3086-3095.
37. Rockett KA, Brookes R, Udalova I, Vidal V, Hill AV, Kwiatkowski D. 1,25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line. Infect Immun. 1998;66:5314-5321.
38. Ren S, Nguyen L, Wu S, Encinas C, Adams JS, Hewison M. Alternative splicing of vitamin D-24-hydroxylase: a novel mechanism for the regulation of extrarenal 1,25-dihydroxyvitamin D synthesis. J Biol Chem. 2005;280:20604-20611.
39. Weisman Y, Jaccard N, Legum C, et al. Prenatal diagnosisofvitamin D-dependent rickets, type II: response to 1,25-dihydroxyvitamin D in amniotic fluid cells and fetal tissues. J Clin Endocrinol Metab. 1990;71:937-943.
40. Chen H, Hewison M, Adams JS. Functional characterization of heterogeneous nuclear ribonuclear protein C1/C2 in vitamin D resistance: a novel response element-binding protein. J Biol Chem. 2006; 281:39114-39120.
41. Muehleisen B, Bikle DD, Aguilera C, et al. PTH/PTHrP and vitamin D control antimicrobial peptide expression and susceptibility to bacterial skin infection. Sci Transl Med 2012;4:135ra66.
42. Willems HM, vandenHeuvel EG, Carmeliet G, Schaafsma A, Klein-Nulend J, Bakker AD. VDR dependent and independent effects of 1,25-dihydroxyvitamin D3 on nitric oxide production by osteoblasts. Steroids. 2012;77:126-131.
43. Sequeira VB, Rybchyn MS, Tongkao-On W, et al. The role of the vitamin D receptor and ERp57 in photoprotection by 1alpha, 25-dihydroxyvitamin D3. Mol Endocrinol. 2012;26:574-582.
44. van Hamburg JP, Asmawidjaja PS, Davelaar N, et al. TNF blockade requires 1,25(OH)2D3 to control human Th17-mediated synovial inflammation. Ann Rheum Dis. 2012;71:606-612.